Terns Pharmaceuticals
(NASDAQ) TERN
Terns Pharmaceuticals Financials at a Glance
Market Cap
$5.62B
Revenue (TTM)
$0.00
Net Income (TTM)
$94.44M
EPS (TTM)
$-1.03
P/E Ratio
-51.22
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$53.13
Volume
19,688,435
Open
$52.84
Price
$53.13
Volume
19,688,435
Open
$52.84
Previous Close
$53.17
Daily Range
$52.78 - $53.19
52-Week Range
$1.86 - $53.19
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$53.13
Volume
19,688,435
Open
$52.84
Previous Close
$53.17
Daily Range
$52.78 - $53.19
52-Week Range
$1.86 - $53.19
TERN News
TERN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Terns Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
59
CEO
Amy L. Burroughs, MBA
Website
www.ternspharma.comHeadquarters
Foster City, CA 94404, US
TERN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-29%
Return on Capital
-38%
Return on Assets
-31%
Earnings Yield
-1.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.62B
Shares Outstanding
106.33M
Volume
19.69M
Short Interest
0.00%
Avg. Volume
3.51M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$101.87M
EBITDA
$100.97M
Operating Cash Flow
$70.02M
Capital Expenditure
$42.00K
Free Cash Flow
$70.06M
Cash & ST Invst.
$358.16M
Total Debt
$1.35M
Terns Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.62B
N/A
Market Cap/Employee
$95.26M
N/A
Employees
59
N/A
Net Income
$24.64M
-12.3%
EBITDA
$24.58M
+0.6%
Quarterly Fundamentals
Net Cash
$294.61M
-20.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$570.00K
-44.8%
Short Term Debt
$459.00K
+68.8%
Return on Assets
-31.31%
N/A
Return on Invested Capital
-37.89%
N/A
Free Cash Flow
$19.77M
-20.2%
Operating Cash Flow
$19.77M
-20.2%